flucytosine and micafungin

flucytosine has been researched along with micafungin in 32 studies

Research

Studies (32)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (3.13)	18.2507
2000's	23 (71.88)	29.6817
2010's	8 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Guarro, J; Mariné, M; Pastor, FJ; Rodríguez, MM; Serena, C	1
Cano, J; Gené, J; Guarro, J; Marimon, R; Serena, C	1
Alastruey-Izquierdo, A; Almirante, B; Cuenca-Estrella, M; Gomez-Lopez, A; Pahissa, A; Rodriguez, D; Rodriguez-Tudela, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Dimopoulos, G; Falagas, ME; Velegraki, A	1
Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL	1
Chittick, P; Delashmitt, B; Evans, J; Palavecino, EL; Peacock, JE	1
Calvo, E; Guarro, J; Pastor, FJ; Rodríguez, MM; Salas, V; Sutton, DA	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Hashiguchi, K; Higashiyama, Y; Hossain, MA; Kohno, S; Maesaki, S; Sasaki, E; Tashiro, T; Tomono, K; Yoshitsugu, Y	1
Fujihara, N; Ichiyama, S; Iinuma, Y; Kudo, T; Saito, T; Takakura, S	1
Abe, N; Aihara, M; Fukuda, S; Iwasaki, M; Komatsu, M; Matsuo, S; Nagasaka, Y; Shimakawa, K	1
Steinbach, WJ	1
Benjamin, DK; Steinbach, WJ; Zaoutis, TE	1
Fernández-Torres, B; Guarro, J; Mariné, M; Pastor, FJ; Serena, C	1
Nakamura, K; Nakasone, I; Ohta, C; Onaga, S; Yamane, N	1
Fukushima, K; Hyon, SH; Park, BJ; Park, JC; Taguchi, H; Takatori, K	1
Guarro, J; Mariné, M; Pastor, FJ; Serena, C	1
Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C	1
Denning, DW; Drusano, GL; Hope, WW; Louie, A; Moore, CB; Sharp, A; Walsh, TJ; Warn, PA	1
Ichikawa, M; Kaneda, M; Kobayashi, R; Nakagawa, A; Sato, T; Suzuki, D	1
Mercier, RC; Pai, MP; Samples, ML; Spilde, MN	1
Guarro, J; Mariné, M; Pastor, FJ	1
Asari, S; Iwatani, Y; Nishi, I; Sunada, A; Toyokawa, M	1
Pai, MP	1
Murakami, H; Tashiro, M; Tateda, K; Yamaguchi, K; Yoshizawa, S	1
Furuya, N; Mano, Y; Morishige, H; Oguri, T	1
Fujisaki, J; Hamada, T; Hirabayashi, D; Kamikawa, Y; Mori, Y; Nagayama, T; Sakamoto, R; Sugihara, K	1
Horiuchi, C; Ikeda, T; Iwanaga, N; Kamiya, C; Katsuragi, S; Kobayashi, Y; Miyoshi, T; Neki, R; Sata, M; Tanaka, H; Yamanaka, K; Yamashita, Y; Yoshimatsu, J	1
Abebaw, Y; Bitew, A	1
Ataollahy, N; Hammarström, H; Kondori, N; Lindberg, E	1

Reviews

4 review(s) available for flucytosine and micafungin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
[The future of antifungal agents. Non azole antifungal agents]. Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology, 1999, Volume: 40, Issue:3 Topics: Amphotericin B; Animals; Antifungal Agents; Drug Carriers; Echinocandins; Flucytosine; Fungi; Glucosyltransferases; Lipopeptides; Lipoproteins; Liposomes; Membrane Proteins; Micafungin; Mice; Mycoses; Peptides, Cyclic; Rats; Schizosaccharomyces pombe Proteins	1999
Antifungal agents in children. Pediatric clinics of North America, 2005, Volume: 52, Issue:3 Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole	2005
Antifungal treatment in pediatric patients. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2005, Volume: 8, Issue:4 Topics: Adolescent; Amphotericin B; Antifungal Agents; Azoles; Caspofungin; Child; Child, Preschool; Drug Resistance, Fungal; Echinocandins; Flucytosine; Fungal Proteins; Humans; Infant; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Triazoles	2005

Other Studies

28 other study(ies) available for flucytosine and micafungin

Article	Year
Combined therapies in a murine model of blastoschizomycosis. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7 Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Flucytosine; Geotrichosis; Geotrichum; Humans; Immunocompromised Host; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Trichosporon; Voriconazole	2007
In vitro antifungal susceptibilities of five species of sporothrix. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2 Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Species Specificity; Sporothrix; Sporotrichosis	2008
Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4 Topics: Antifungal Agents; Candida; Candidiasis; Fungemia; Humans; Microbial Sensitivity Tests; Population Surveillance; Prevalence; Spain; Species Specificity	2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
A 10-year survey of antifungal susceptibility of candidemia isolates from intensive care unit patients in Greece. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3 Topics: Antifungal Agents; Candida; Candidiasis; Data Collection; Disease Susceptibility; Greece; Humans; Intensive Care Units; Microbial Sensitivity Tests; Retrospective Studies	2009
Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5 Topics: Acremonium; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Echinocandins; Fungi; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Penicillium; Scedosporium; Spain	2009
Case of fatal Blastoschizomyces capitatus infection occurring in a patient receiving empiric micafungin therapy. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12 Topics: Aged; Antifungal Agents; Echinocandins; Fatal Outcome; Geotrichosis; Geotrichum; Humans; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Neutropenia	2009
Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12 Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Kidney; Male; Mice; Mucormycosis; Rhizopus; Triazoles	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin. The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:2 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Echinocandins; Flucytosine; Humans; Itraconazole; Japan; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2004
[In vitro activity of a new semisynthetic echinocandin, micafungin, against clinical isolates of Candida species isolated in Tenri Hospital]. The Japanese journal of antibiotics, 2003, Volume: 56, Issue:6 Topics: Amphotericin B; Antifungal Agents; Candida; DNA Fingerprinting; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Hospitals; Humans; Itraconazole; Japan; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Random Amplified Polymorphic DNA Technique; Time Factors	2003
Activities of flucytosine, fluconazole, amphotericin B, and micafungin in a murine model of disseminated infection by Candida glabrata. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:11 Topics: Amphotericin B; Animals; Antifungal Agents; Candida glabrata; Candidiasis; Echinocandins; Fluconazole; Flucytosine; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Microbial Sensitivity Tests; Peptides, Cyclic	2005
[Antifungal susceptibility among the isolates of yeast from the University Hospital of the Ryukyus]. Rinsho Biseibutsu Jinsoku Shindan Kenkyukai shi = JARMAM : Journal of the Association for Rapid Method and Automation in Microbiology, 2005, Volume: 16, Issue:2 Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Japan; Lipopeptides; Lipoproteins; Micafungin; Miconazole; Minimally Invasive Surgical Procedures; Peptides, Cyclic	2005
Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts. Biochemical and biophysical research communications, 2006, Aug-25, Volume: 347, Issue:2 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Catechin; Dose-Response Relationship, Drug; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Miconazole; Microbial Sensitivity Tests; Peptides, Cyclic; Species Specificity	2006
Combined antifungal therapy in a murine infection by Candida glabrata. The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:6 Topics: Amphotericin B; Animals; Antifungal Agents; Candida glabrata; Candidiasis; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Fluconazole; Flucytosine; Immunocompromised Host; Kidney; Lipopeptides; Lipoproteins; Micafungin; Mice; Peptides, Cyclic; Spleen; Survival Analysis	2006
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:12 Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole	2006
Effect of neutropenia and treatment delay on the response to antifungal agents in experimental disseminated candidiasis. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:1 Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Disease Models, Animal; Dose-Response Relationship, Drug; Echinocandins; Flucytosine; Kidney; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Microbial Sensitivity Tests; Neutropenia; Neutrophils; Peptides, Cyclic; Time Factors	2007
Current approaches to management of cerebral fungal infection in pediatric patients with hematologic disorders. Journal of pediatric hematology/oncology, 2008, Volume: 30, Issue:3 Topics: Adolescent; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Central Nervous System Fungal Infections; Child; Drug Combinations; Echinocandins; Fatal Outcome; Female; Flucytosine; Follow-Up Studies; Graft Rejection; Hematologic Diseases; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Lipoproteins; Magnetic Resonance Imaging; Male; Micafungin; Mucormycosis; Peripheral Blood Stem Cell Transplantation; Remission Induction; Treatment Outcome	2008
Activities and ultrastructural effects of antifungal combinations against simulated Candida endocardial vegetations. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7 Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Endocarditis; Flucytosine; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Models, Biological; Pyrimidines; Triazoles; Voriconazole	2008
Combined antifungal therapy in a murine model of disseminated infection by Cladophialophora bantiana. Medical mycology, 2009, Volume: 47, Issue:1 Topics: Amphotericin B; Animals; Antifungal Agents; Ascomycota; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Flucytosine; Humans; Lipopeptides; Male; Micafungin; Mice; Mycoses; Treatment Outcome; Triazoles	2009
In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2009, Volume: 15, Issue:1 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Synergism; Echinocandins; Fluconazole; Flucytosine; Humans; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole	2009
Antifungal combinations against simulated Candida albicans endocardial vegetations. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6 Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Drug Combinations; Echinocandins; Endocarditis; Flucytosine; Humans; Lipopeptides; Micafungin	2009
[Isolation rate and susceptibilities of candida species from blood, vascular catheter, urine and stool]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2012, Volume: 86, Issue:2 Suppl 4 Topics: Antifungal Agents; Candida; Candidiasis; Diagnosis, Differential; Echinocandins; Feces; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Vascular Access Devices	2012
Comparison of four reading methods of broth microdilution based on the clinical and laboratory standards institute M27-A3 method for Candida spp. The Japanese journal of antibiotics, 2012, Volume: 65, Issue:5 Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Lipopeptides; Micafungin; Miconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2012
Frequency of clinically isolated strains of oral Candida species at Kagoshima University Hospital, Japan, and their susceptibility to antifungal drugs in 2006-2007 and 2012-2013. BMC oral health, 2014, Feb-20, Volume: 14 Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Autoimmune Diseases; Bacterial Load; Candida; Candida albicans; Candida glabrata; Candidiasis, Oral; Coinfection; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Japan; Lipopeptides; Male; Micafungin; Miconazole; Microbial Sensitivity Tests; Middle Aged; Xerostomia	2014
Antifungal susceptibility of Candida isolates at one institution. Medical mycology journal, 2014, Volume: 55, Issue:1 Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidemia; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Health Facilities; Humans; Itraconazole; Japan; Lipopeptides; Micafungin; Time Factors; Voriconazole	2014
Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern. BMC women's health, 2018, 06-15, Volume: 18, Issue:1 Topics: Adolescent; Adult; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Caspofungin; Cross-Sectional Studies; Drug Resistance, Fungal; Ethiopia; Female; Fluconazole; Flucytosine; Humans; Micafungin; Microbial Sensitivity Tests; Middle Aged; Prevalence; Reproductive Tract Infections; Sexual Partners; Voriconazole; Young Adult	2018
Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia. Scientific reports, 2019, 03-07, Volume: 9, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candidemia; Caspofungin; Child; Child, Preschool; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Triazoles; Voriconazole; Young Adult	2019